The HCPLive schizophrenia page is a resource for medical news and expert insights on the mental disorder. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for schizophrenia, and more.
November 22nd 2024
A study identified homelessness and minority status as factors that impact clozapine prescription patterns.
November 14th 2024
Talking About Tardive Dyskinesia with Dr. Stanley Caroff: Part 2
Dr. Stanley Caroff, Emeritus Professor CE of Psychiatry at the Philadelphia VA Medical Center, sits down with MD Magazine to explain what tardive dyskinesia is, and why it's so important for psychiatrists to be aware of this side effect in their patients taking antipsychotic medications. This is the conclusion of a two-part conversation.
Antipsychotic Polypharmacy Rate Remains High Following Hospital Discharge
November 4th 2016Despite greater scrutiny on this practice in recent years, too many patients with schizophrenia and other serious mental illnesses are discharged from inpatient hospital stays while still taking multidrug regimens of antipsychotic medications.
Mark Komrad: Progressing from Scholarship to Activism for a Cause
The issue of physician assisted suicide can cause people to fervently pick one side or another. For some, their belief is so strong that they are moved to do things they may not have done in their career beforehand.
Mark Komrad: Physician Assisted Suicide a Difficult Topic for Psychiatrists
For many psychiatrists one of their biggest challenges in their daily practice is working to show patients that suicide is not the solution to their problems. Changes in the criteria for physician assisted suicide in Europe which include allowing mental illness as a criteria can fly in the face of that mission.
Lipid Screening Is Underutilized in Adults Treated with Antipsychotics
August 31st 2016Research suggests that lipid screening appears to remain particularly underutilized in adults taking antipsychotic medications, despite improvements in recent years in the use of diabetes screening in this patient population.
In the field of oncology the use of targeted medications is becoming more commonplace to address various conditions. Research is being done in other areas of medicine, including psychiatry to see if there is more that can be done to address this patient population as well.
Mary Giliberti from NAMI: Working to Make Mental Health a 'Casserole Illness'
Talking about mental health conditions may be easier than it was a few years ago but the stigma still exists in many parts of the population. The National Alliance on Mental Illness is working to overcome that issue on a variety of fronts.
David Nicholson from Allergan: Cariprazine Aims to Further Antipsychotic Market for Mental Health
Allergan has made a name for itself in the treatment of many neurological and mental health conditions and continues to grow its portfolio. One of its newest offerings is cariprazine which they hope will be a powerful tool in the antipsychotic area.